Glucokinase Activators comprise a diverse set of chemical compounds that facilitate the enzyme's ability to catalyze the phosphorylation of glucose, thereby playing a pivotal role in glucose metabolism and homeostasis. Glucose itself is the principal physiological activator, bolstering Glucokinase's affinity for its substrate when glucose levels in the blood escalate, thereby enhancing the glycolytic pathway. Similarly, fructose-1-phosphate frees Glucokinase from its inhibitory complex with the Glucokinase regulatory protein (GKRP), thus increasing its activity within the liver. Additionally, compounds like mannose, sorbitol, and glucosamine, which serve as substrates for Glucokinase or its related pathways, can elevate the enzyme's activity by increasing substrate availability. Glyceraldehyde, through its phosphorylated derivative, and N-acetylglucosamine, by providing additional phosphorylation targets, contribute to an augmented glycolytic throughput, reinforcing Glucokinase action.
Glucokinase Activators encompass a spectrum of chemical compounds that amplify the functional activity of Glucokinase, a key enzyme in glucose metabolism. Central to this group is glucose, which directly augments Glucokinase activity by binding to the enzyme and enhancing its affinity for glucose, thus facilitating the conversion of glucose to glucose-6-phosphate, a critical step in glycolysis. Other activators, such as fructose-1-phosphate and fructose-6-phosphate, exert their effects allosterically or through participation in glycolytic feedback loops, respectively, leading to an increase in Glucokinase's catalytic efficiency. Similarly, mannose, glucosamine, and N-acetylglucosamine act as substrates that can elevate enzyme activity by increasing the pool of phosphorylatable sugars. The metabolic intermediates sorbitol and xylitol, through their respective conversion to fructose and xylulose-5-phosphate, contribute to enhanced Glucokinase activity by indirectly influencing its substrate availability and the flux through the pentose phosphate pathway.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
D(+)Glucose, Anhydrous | 50-99-7 | sc-211203 sc-211203B sc-211203A | 250 g 5 kg 1 kg | $37.00 $194.00 $64.00 | 5 | |
Glucose is the primary physiological activator of Glucokinase by increasing its affinity for glucose. When glucose levels rise, Glucokinase's catalytic activity is enhanced as it phosphorylates glucose to glucose-6-phosphate, which is a crucial step in glycolysis. | ||||||
D-Mannose | 3458-28-4 | sc-211180 sc-211180A | 100 g 250 g | $101.00 $158.00 | 1 | |
Mannose is phosphorylated by Glucokinase to mannose-6-phosphate, which enters glycolysis. Elevated levels of mannose can promote Glucokinase activity due to increased substrate availability. | ||||||
D-Sorbitol | 50-70-4 | sc-203278A sc-203278 | 100 g 1 kg | $28.00 $68.00 | ||
Sorbitol can be converted to fructose by sorbitol dehydrogenase; fructose can then be phosphorylated to fructose-1-phosphate, which acts as an allosteric activator of Glucokinase. | ||||||
D-Glucosamine | 3416-24-8 | sc-278917A sc-278917 | 1 g 10 g | $197.00 $764.00 | ||
Glucosamine is phosphorylated by Glucokinase, and its increased presence can enhance the activity of Glucokinase indirectly by increasing substrate availability. | ||||||
N-Acetyl-D-glucosamine | 7512-17-6 | sc-286377 sc-286377B sc-286377A | 50 g 100 g 250 g | $92.00 $159.00 $300.00 | 1 | |
N-Acetylglucosamine can be phosphorylated by Glucokinase, potentially enhancing enzyme activity due to the increased availability of substrates for phosphorylation. | ||||||
Insulin | 11061-68-0 | sc-29062 sc-29062A sc-29062B | 100 mg 1 g 10 g | $153.00 $1224.00 $12239.00 | 82 | |
Insulin indirectly enhances Glucokinase activity by promoting its dephosphorylation and translocation to the cytoplasm where it can phosphorylate glucose more effectively. | ||||||
BADGE | 1675-54-3 | sc-202487 sc-202487A sc-202487B sc-202487C | 25 g 50 g 100 g 500 g | $38.00 $50.00 $63.00 $189.00 | 3 | |
BADGE has been shown to increase Glucokinase activity indirectly by inhibiting PPARγ, which leads to increased insulin secretion and thereby enhances Glucokinase activity. | ||||||